CPG-10101

N/A

Report date: 2022/07/19 16:22:54

NME

Base Information

Drug NameCPG-10101

Drug Alias NameCPG-10101

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionToll like receptor 9 agonists

TargetsToll like receptor 9

Therapy Area/IndicationsHepatitis, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHepatitis, Chronic

ATC CodeN/A